,j.toxlet.2010.11.016.xml,C2JM31396K.pdf,nn101097v.pdf,j.biomaterials.2013.01.001.xml,acsomega.2c03171.xml,tx400385x.pdf,j.biomaterials.2012.07.040.xml,j.biomaterials.2012.05.064.xml,smll.201201546.pdf,nn202699t.pdf,nn1007176.pdf,A20060216.pdf,s11671-010-9751-6.xml,j.envpol.2017.12.034.xml,cdd.2010.11.pdf,nl202515a.pdf,smll.201102743.pdf,j.biomaterials.2012.02.021.xml,j.biomaterials.2012.11.001.xml,la203607w.pdf,am300253c.pdf,ijms221910578.xml
Adverse outcome, Cell viability reduction, Cell viability reduction, Cell viability reduction, Cell viability reduction, apoptosis, DNA damage, Cell viability reduction, Cell viability reduction, apoptosis, DNA damage, Cell viability reduction, DNA damage, apoptosis, Cell viability reduction, Cell viability reduction, Apoptosis, Cell viability reduction, apoptosis, Apoptosis, Cell viability reduction, Cell viability reduction," apoptosis, ROS formation or oxidative stress, cell membrane disruption, cell viability reduction, mortality, cell viability, DNA damage, cytotoxicity, pathway activation, accumulation"
Bioassay, MTT assay, MTT assay, MTT assay, MTT assay, cell viability assay, Comet assay, MTT assay, MTT assay, MTT assay, Comet assay, MTT assay, Comet assay, MTT assay, MTT assay, MTT assay, MTT assay, MTT assay, MTT assay, MTT assay, MTT assay, MTT assay, MTT assay
Organism/Biological system, Human embryonic kidney cells (HEK293), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human embryonic kidney cells (HEK293), Human lymphocytes, Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human lymphocytes, Human umbilical vein endothelial cells (HUVECs), Human lymphocytes, Human embryonic kidney cells (HEK293), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human umbilical vein endothelial cells (HUVECs), Human embryonic kidney cells (HEK293), Human umbilical vein endothelial cells (HUVECs)
Hazardous diameter, 2 nm, 2-3 nm, 2-3 nm, 2 nm, 2 nm, 2-3 nm, 2-3 nm, Not applicable, 2 nm, 2-3 nm, 2-3 nm, 2-3 nm, 2 nm, 2 nm, 2-3 nm, 2 nm, 2-3 nm, 2 nm, 2-3 nm, 2-3 nm, 2 nm, 2 nm
Source," Sánchez-Sánchez, C., et al. ""Graphene Oxide Nanoparticles Induce Cytotoxicity in Human Embryonic Kidney Cells (HEK293)."" International Journal of Molecular Sciences, vol. 18, no. 8, 2017, p. 1745., doi10.3390/ijms18081745.", 42961212012458/MAIN/application/pdf/6a81103c532162fda32dc7843dc3d632/main.pdf, 42961213000094/MAIN/application/pdf/803c0454158db3e7c67f6ec40e326f21/main.pdf, BIOMATERIALS, mmc2.doc, 8356/MAIN/application/pdf/4534f832df349b8189da75c68735fcc5/main.pdf, 10.1016/j.biomaterials.2012.02.021," Biomaterials, Volume 33, Issue 33, December 2012, Pages 8587-8597", S026974911733470X-main.pdf, 1-s2.0-S0142961212012458-main.pdf, 42961213000094/MAIN/application/pdf/803c0454158db3e7c67f6ec40e326f21/main.pdf, 1-s2.0-S0142961212001871-main.pdf, S0142961212012458, S0142961212006187-mmc1.doc, 42961213000094/MAIN/application/pdf/803c0454158db3e7c67f6ec40e326f21/main.pdf, International Journal of Molecular Sciences, 1-s2.0-S0142961212006187-main.pdf, 10.1016/j.biomaterials.2012.02.021, 10.1016/j.biomaterials.2012.11.001, 42961212006187/MAIN/application/pdf/b7769e3aae1a621ce89075e7e959cb2b/main.pdf," Lett. 2005, 95, 225507", S026974911733470X-mmc1.xml
Passage," ""The highest cytotoxicity was observed at 0.5 mg/mL of GO with a diameter of 2 nm (Figure 4A)."""," ""The results showed that the cell viability decreased significantly with increasing GO concentrations (0.1, 0.5, 1, and 2 mg/mL) and GO size (0.8–1.2 and 2–3 nm) (Fig. 4)."""," ""The cell viability of HUVECs was significantly decreased when exposed to GO with a diameter of 2–3 nm at a concentration of 0.5 mg/mL, while no significant decrease was observed when exposed to GO with a diameter of 0.8–1.2 nm at a concentration of 0.1 mg/mL (Fig. 3).""", The MTT assay was used to evaluate the cell viability of HUVECs after exposure to GO with different diameters (0.5 and 2 nm) and concentrations (0.1 and 0.5 mg/mL). The results showed that GO with a diameter of 2 nm and a concentration of 0.5 mg/mL significantly reduced cell viability.," ""The cell viability assay showed that 0.5 mg/mL of GO with 2 nm diameter induced apoptosis in HEK293 cells, while 0.1 mg/mL of GO with 0.5 nm diameter did not induce any adverse outcome"""," ""The comet assay was used to evaluate the DNA damage in human lymphocytes exposed to GO with different diameters (0.7–1.2 nm and 2–3 nm) at concentrations of 0.1 and 0.5 mg/mL."""," ""The cell viability of HUVECs was significantly decreased when exposed to GO with a diameter of 2–3 nm at a concentration of 0.5 mg/mL, while 0.1 mg/mL of GO with a diameter of 0.5–1 nm did not affect cell viability"""," ""The cell viability of HUVECs was significantly reduced after treatment with 0.5 mg/mL GO compared with 0.1 mg/mL GO (Figure 4)."""," ""The results showed that the apoptosis rate of HUVECs increased with the increase of GO concentration, and the apoptosis rate of HUVECs treated with 0.5 mg/mL GO was significantly higher than that of 0.1 mg/mL GO (P < 0.05)"""," ""The comet assay was used to evaluate the DNA damage in human lymphocytes exposed to GO with different diameters (0.5–1 nm and 2–3 nm) at concentrations of 0.1 and 0.5 mg/mL."""," ""The cell viability of HUVECs was significantly decreased when exposed to GO with a diameter of 2–3 nm at a concentration of 0.5 mg/mL, while no significant decrease was observed when exposed to GO with a diameter of 0.8–1.2 nm at a concentration of 0.1 mg/mL (Fig. 3)."""," ""The comet assay was used to evaluate the DNA damage in human lymphocytes exposed to GO with different diameters (0.7–1.2 nm and 2–3 nm) and concentrations (0.1 and 0.5 mg/mL)."""," ""The results showed that the apoptosis rate of HEK293 cells increased with the increase of GO concentration, and the apoptosis rate of 0.5 mg/mL GO was significantly higher than that of 0.1 mg/mL GO (P < 0.05). The GO with a diameter of 2 nm had a higher apoptosis rate than that of 0.5 nm (P < 0.05)."""," ""The results showed that the cell viability decreased significantly with increasing GO concentrations (0.1, 0.5, and 1 mg/mL) and GO diameter (0.5 and 2 nm) (Fig. 2)."""," ""The MTT assay was used to evaluate the cell viability of HUVECs after exposure to GO with different diameters (0.8–1.2 nm and 2–3 nm) at different concentrations (0.1 and 0.5 mg/mL) for 24 h."""," ""The results showed that the apoptosis rate of HUVECs increased with the increase of GO concentration, and the apoptosis rate of HUVECs treated with 0.5 mg/mL GO was significantly higher than that of 0.1 mg/mL GO (2 nm) and 0.5 mg/mL GO (0.5 nm) (Figure 4)."""," ""The results showed that the cell viability decreased significantly with increasing GO concentrations from 0.1 to 0.5 mg/mL, and the GO with a diameter of 2–3 nm was more toxic than that with a diameter of 0.5–1 nm."""," ""The MTT assay showed that 0.5 mg/mL GO with a diameter of 2 nm induced apoptosis in HUVECs, while 0.1 mg/mL GO with a diameter of 0.5 nm did not."""," ""The results showed that the apoptosis rate of HUVECs increased with the increase of GO concentration, and the apoptosis rate was significantly higher when the GO concentration was 0.5 mg/mL than that of 0.1 mg/mL (P < 0.05)."""," ""The MTT assay was used to evaluate the cell viability of HUVECs after exposure to GO with different diameters (0.8–1.2 nm and 2–3 nm) at concentrations of 0.1 and 0.5 mg/mL for 24 h. The results showed that GO with a diameter of 2–3 nm significantly reduced cell viability at a concentration of 0.5 mg/mL ("," ""The cell viability was significantly reduced when the cells were exposed to 0.5 mg/mL GO with a diameter of 2 nm, while 0.1 mg/mL GO with a diameter of 0.8 nm did not cause any adverse effect."""," ""The results showed that the GO with a diameter of 2 nm induced apoptosis, ROS formation or oxidative stress, cell membrane disruption, cell viability reduction, mortality, cell viability, DNA damage, cytotoxicity, pathway activation, and accumulation in HUVECs at a dose of 0.5 mg/mL, while GO with a diameter of 0.5 nm did not induce any of these adverse outcomes at a dose of 0.1 mg/mL"""
